VKH
VTVT icon

Virtu KCG Holdings’s vTv Therapeutics VTVT Stock Holding History

Virtu KCG Holdings’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-578
Closed -$151K – 3974
2015
Q3 		$151K Buy
+578
New +$201K ﹤0.01% 2693

Other funds holding VTVT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PSC
Piper Sandler & Co Minneapolis, Minnesota $102M AUM 0.13% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Virtu KCG Holdings's VTVT Position: Q4 2015 in Review

Virtu KCG Holdings sold out of vTv Therapeutics (VTVT) in Q4 2015, closing a stake of 578 shares — an estimated $151K sold.

Virtu KCG Holdings first reported a position in VTVT in Q3 2015 and held it in 1 quarter. The position peaked at $151K in Q3 2015. 42 funds tracked by Wall St. Rank hold VTVT as of Q4 2015.

  • Virtu KCG Holdings reported no remaining vTv Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Virtu KCG Holdings sold 578 vTv Therapeutics shares in Q4 2015, an estimated $151K.
  • Virtu KCG Holdings first reported a position in vTv Therapeutics in Q3 2015 and held it in 1 quarter.
  • Virtu KCG Holdings's vTv Therapeutics position peaked at $151K in Q3 2015.
  • 42 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2015.

Based on Virtu KCG Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.